Suven Life Sciences Limited (BOM:530239)
India · Delayed Price · Currency is INR 267.85
-10.60 (-3.81%)
At close: Oct 22, 2026
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 75.68 billion as of October 22, 2026. It is the 11,297th most valuable company in the world and the 667th biggest in India. Its market cap has increased by 68.63% in one year.
Market Cap
75.68B
Enterprise Value
70.67B
Revenue
88.14M
Global Rank
Country Rank
#667 India
PE Ratio
n/a
ChartMarket Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 75.68B, an increase of 4,596.52%. That is a compound annual growth rate of 17.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 75.68B | 99.41% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 246.65B |
| Shilpa Medicare | 171.32B |
| Symbiotec Pharmalab | 79.59B |
| IOL Chemicals and Pharmaceuticals | 53.61B |
| Gujarat Themis Biosyn | 46.74B |
| NGL Fine-Chem | 17.05B |
| Bajaj HealthCare | 11.43B |
| Shree Ganesh Remedies | 8.88B |